Omega-3 Benefits: Skin, Mood and Recovery

Nutrition Science  ·  Supplement Education

Omega-3 benefits for skin, mood, and recovery: what the evidence actually shows

// The short answer

EPA and DHA, the active forms of omega-3, support skin barrier integrity, reduce inflammatory lesion counts in acne studies, and show genuine (if modest) evidence for mood and exercise recovery. The catch: plant-based ALA converts at under 10% efficiency, and most people are chronically low. A quality fish or algae oil at 2g EPA and DHA per day for at least 12 weeks is the practical starting point.

Omega-3 is one of those nutrients that gets both overclaimed and dismissed. The overclaim side loads it with cardiovascular promises that the RCT evidence has largely deflated at typical doses.5 The dismissal side misses what the data genuinely supports: skin barrier function, inflammatory resolution, and recovery from training. This guide cuts through both.

Habib A MuflihFounder of MAXXING | Last updated: June 2026 | 14 min read Educational supplement guide. Not medical advice, diagnosis, or treatment. Consult a healthcare provider before starting any supplement regimen, especially if pregnant, breastfeeding, on blood thinners, or managing a diagnosed condition.
41.9%
Reduction in total acne lesions in 10-week RCT at 2g EPA+DHA/day
Khayef et al. 2012
36%
Increase in minimal erythemal dose (UV protection) with fish oil supplementation
Rhodes et al. 1995
<1%
ALA-to-DHA conversion efficiency in most adults; pre-formed EPA+DHA essential
Burdge & Calder 2005
~8wks
Minimum supplementation duration to reach measurable tissue incorporation
Harris & von Schacky 2004
// What's in this guide
  1. What are omega-3 fatty acids?
  2. Omega-3 and skin: barrier, acne, and UV protection
  3. Omega-3 and mood
  4. Omega-3 and exercise recovery
  5. Evidence strength at a glance
  6. Sources compared: fish oil, algae, krill, ALA
  7. How much and when
  8. Quality and the oxidation problem
  9. Stacking with other nutrients
  10. FAQ

01What are omega-3 fatty acids?

Omega-3 refers to a family of polyunsaturated fatty acids where the first double bond sits three carbons from the methyl end of the chain. Three members matter for human health: ALA (alpha-linolenic acid, 18 carbons), EPA (eicosapentaenoic acid, 20 carbons), and DHA (docosahexaenoic acid, 22 carbons). ALA is technically the only essential one: your body cannot make it, so it must come from food. EPA and DHA can theoretically be synthesized from ALA, but the conversion rate is too low to matter in practice for most people.17

EPA and DHA are the forms that drive the biological effects people care about. They get incorporated into cell membrane phospholipids throughout the body, displacing arachidonic acid (an omega-6 fatty acid) in the process. When a cell is damaged or stressed, it releases fragments from its membrane to signal inflammation. If those fragments are EPA- and DHA-derived rather than arachidonic acid-derived, the resulting signaling molecules are far less inflammatory and, in the case of resolvins, actively pro-resolution: they switch off the inflammatory response rather than just dampening it.35

This competitive displacement is the master mechanism behind most omega-3 benefits. It explains why skin inflammation, post-exercise soreness, and mood-related inflammatory processes all potentially respond to the same nutrient, and it explains why the ratio of omega-6 to omega-3 in your diet matters as much as absolute omega-3 intake. Western diets run an omega-6:omega-3 ratio of roughly 15:1 to 20:1. The evolutionary baseline is thought to be closer to 4:1.13

// Key takeaway

EPA and DHA are the active forms. They work by displacing pro-inflammatory omega-6 from cell membranes and generating anti-inflammatory and pro-resolution signaling molecules called resolvins. Plant-based ALA is a poor substitute at typical conversion rates. Most people in Western populations are chronically below optimal omega-3 status.

02Omega-3 and skin: barrier, acne, and UV protection

Skin is one of the strongest application areas for omega-3 research. The epidermis has high fatty acid turnover, and the stratum corneum's lipid bilayers, which control transepidermal water loss and barrier function, depend directly on the quality of dietary fats available to rebuild them.9 Three mechanisms stand out.

Skin barrier integrity

EPA and DHA are structural components of skin cell membrane phospholipids. A deficiency in essential fatty acids produces characteristic scaly, inflamed dermatitis with increased transepidermal water loss, a clinical sign that has been documented in patients on fat-free parenteral nutrition.36 In populations with atopic dermatitis or eczema, where barrier dysfunction is central to the condition, several RCTs have found improvements with omega-3 supplementation, though results across trials are mixed.40 For people without a diagnosed condition, correction of a genuine deficiency is the clearest benefit; the marginal gain from supplementing above adequacy is more variable.

Inflammatory acne

The acne evidence is more consistent than many people expect. A 2018 meta-analysis of seven RCTs (total n=378) found omega-3 supplementation significantly reduced inflammatory lesion count (WMD -5.31, 95% CI -9.49 to -1.13, p=0.013) and total lesion count versus control.38 An earlier 10-week double-blind RCT in 58 adults with mild-to-moderate acne showed a 42% reduction in inflammatory lesions with 3g per day EPA and DHA.10 A separate RCT comparing omega-3 versus GLA versus control over 10 weeks reported a 41.9% total lesion reduction in the omega-3 group.2

The mechanism runs through two pathways: competitive inhibition of arachidonic acid in the COX and LOX enzyme pathways, reducing leukotriene B4 and pro-inflammatory prostaglandins; and potential suppression of IGF-1-driven sebocyte proliferation, which may reduce the cellular activity that overproduces sebum in the first place.4 A Korean cross-sectional study of 1,236 adults found that higher omega-3 dietary intake was independently associated with lower acne prevalence (OR 0.68), with a stronger association for inflammatory subtype.11

Worth being honest about the limits: effect sizes in the RCTs are modest (around 5 to 6 fewer lesions on average), sample sizes are small, and omega-3 is not a replacement for established acne treatments. It is a useful supporting measure, particularly if dietary omega-3 is already low.

UV photoprotection

This one is underappreciated. A systematic review of nine human studies found that EPA supplementation consistently increased the minimal erythemal dose, the UV dose required to cause visible skin reddening, with effect sizes ranging from 8% to 45% depending on dose and duration.6 A double-blind RCT with 4g per day EPA for 12 weeks found significantly lower UV-induced MMP-1 (collagenase) expression post-irradiation, suggesting a reduction in UV-driven collagen breakdown, a key mechanism in photoaging.7 An earlier crossover RCT at 10g per day fish oil showed a 36% MED increase alongside reduced sunburn cell formation.8

This does not mean omega-3 replaces sunscreen. SPF is still non-negotiable. But the data suggests EPA in particular reduces the extent of inflammatory and collagen-degrading damage from UV exposure that gets through, which is relevant for anyone thinking about long-term skin health optimization.

// Key takeaway

Omega-3 supports skin in three ways: structural barrier integrity (clearest in deficiency states), modest but statistically significant reduction in inflammatory acne lesions across multiple RCTs, and UV photoprotection via EPA's inhibition of UV-induced collagenase activity. None of these replace topical treatments; all are worth adding to the foundation.

03Omega-3 and mood

The brain is roughly 60% fat by dry weight, and DHA makes up around 30% of the fatty acids in neural cell membranes. EPA does not accumulate in brain tissue in large amounts, but it appears to be the more active fraction for mood effects, likely because of its role in regulating inflammatory cytokines in the central nervous system rather than direct structural incorporation.

The clinical picture here is more nuanced than for skin. Multiple meta-analyses of omega-3 supplementation in diagnosed major depressive disorder have found statistically significant benefits, with EPA-dominant formulations showing stronger effects than DHA-dominant ones. The signal is real but the effect sizes are modest, the studies are heterogeneous, and most used omega-3 as an adjunct to other treatment rather than as a standalone. Applying that clinical data directly to healthy populations looking for a mood boost or stress resilience benefit requires more caution.

What the biology does support clearly: chronic low-grade inflammation, driven in part by a high omega-6:omega-3 ratio, is associated with worse mood states and reduced stress resilience. EPA-derived resolvins and protectins actively downregulate neuroinflammatory processes. This is a plausible mechanism for why people in well-nourished populations with higher omega-3 index scores tend to report better subjective wellbeing in observational studies, though causality is hard to prove in that direction. For anyone already tracking their supplement stack, EPA at 1 to 2g per day is a low-risk, biologically sound addition with reasonable mood-adjacent rationale.

// Key takeaway

EPA appears more relevant than DHA for mood. The clinical evidence is solid in diagnosed depression as an adjunct treatment; the effect in healthy populations is biologically plausible but less firmly established. Reducing chronic neuroinflammation via a better omega-6:omega-3 ratio is a genuine mechanism, even if it does not translate to a dramatic subjective difference for everyone.

04Omega-3 and exercise recovery

Training produces acute inflammation as part of the adaptation signal, and the question is not how to eliminate that signal but how to resolve it efficiently. Omega-3s, particularly via EPA-derived Resolvin E1, accelerate the resolution phase of exercise-induced inflammation rather than blunting the initial response.35 Several RCTs have found reductions in delayed onset muscle soreness (DOMS) and inflammatory markers like IL-6 and CRP after high-intensity exercise in omega-3-supplemented groups. Effect sizes are moderate and most studies used doses of 2 to 4g per day EPA and DHA.

For practical purposes: omega-3 is not a recovery shortcut in the same category as sleep or adequate protein intake, but it is a sensible background measure that supports the anti-inflammatory resolution process without suppressing the adaptive stimulus that drives progress. This is a meaningful distinction from NSAIDs, which can blunt both the soreness and the training adaptation. Omega-3 does not appear to do that based on current evidence. For anyone training consistently and thinking about recovery from a nutritional angle, the supplement stacking guide covers how omega-3 fits with other evidence-based recovery tools.

// Key takeaway

Omega-3 supports resolution of exercise-induced inflammation through the resolvin pathway, reducing muscle soreness and inflammatory markers in several RCTs without appearing to suppress training adaptation. It is a background measure, not a primary recovery tool, but it is well-positioned in a recovery-focused stack at 2 to 3g per day EPA and DHA.

05Evidence strength at a glance

Not all omega-3 claims are equally supported. The table below rates the major benefit areas by the strength of available human evidence, with an honest note on where the literature has limitations.

Table 1 - Omega-3 benefit areas: evidence rating summary
Benefit area Evidence strength Best-supported form Honest limitation
Inflammatory acne reduction Moderate-Good (meta-analysis of 7 RCTs) EPA+DHA combined Effect sizes modest; small sample sizes in individual trials38
Skin barrier support (in deficiency) Good (clinical deficiency well-documented) EPA+DHA Marginal benefit above adequacy is variable9
UV photoprotection (MED increase) Moderate (systematic review, 9 studies) EPA (more than DHA) Doses in trials higher than typical supplements (4-10g/day)6
Reduction in UV-induced collagenase Moderate (double-blind RCT) EPA Single trial, n=26; needs replication7
Mood support / stress resilience Moderate in clinical depression (adjunct); Weak in healthy populations EPA-dominant formulas Most RCTs in diagnosed populations; healthy-population data is largely observational
Exercise recovery (DOMS, inflammation markers) Moderate (multiple RCTs) EPA+DHA Variable protocols across studies; most used high doses (2-4g/day)
Hair growth (telogen effluvium) Preliminary (single RCT with confounders) EPA+DHA + antioxidants One 6-month RCT used a combination supplement; omega-3 not isolated as the active12
Cardiovascular outcomes Weak-to-neutral at typical doses EPA+DHA Meta-analysis of 13 RCTs found no significant reduction in major vascular events at ~840mg/day5
Evidence ratings reflect human clinical data only. Mechanistic and in vitro studies provide supporting rationale but are not rated as clinical evidence. All benefit descriptions use supports-language; these are not medical claims.

The cardiovascular row deserves a note. A widely-cited 2018 meta-analysis in JAMA Cardiology pooled 10 trials (n=77,917) and found no significant reduction in coronary heart disease at the typical supplemental dose of around 840mg per day.5 This does not mean omega-3 has no cardiovascular relevance, only that the dose matters and that the skin, mood, and recovery applications have a stronger evidence profile at the doses people actually take. The triglyceride-lowering effect remains robust at prescription doses (3 to 4g per day), which is a different clinical context.

06Sources compared: fish oil, algae oil, krill, and ALA

The source of your EPA and DHA matters less than the dose, but it matters for tolerability, sustainability, and special dietary needs. Here is how the main options compare.

Table 2 - Omega-3 source comparison (informational)
Source Provides EPA+DHA? Bioavailability Notable properties Suitable for vegans?
Fish oil (triglyceride form) Yes: EPA and DHA Good; well-established plasma incorporation data Most-studied form; wide dose range available; fish smell/taste in some products; oxidation risk if poorly stored34 No
Algae oil Yes: EPA and DHA (or DHA-only in some products) Equivalent to fish oil at matched doses19 The primary source fish eat; no mercury or PCB concerns; sustainable; no fishy aftertaste; cleanest option for vegans20 Yes
Krill oil (phospholipid form) Yes: EPA and DHA Comparable to fish oil at equivalent EPA+DHA doses21 Contains astaxanthin (antioxidant); phospholipid binding may improve tolerability for some; typically lower EPA+DHA per capsule; more expensive per gram of EPA+DHA22 No
ALA (flaxseed, chia, walnuts) No: must convert to EPA/DHA Poor: ALA-to-EPA around 5-10%; ALA-to-DHA under 1% in most adults17 Conversion further reduced by high omega-6 intake and FADS gene variants; adequate for ALA adequacy but not a reliable source of EPA or DHA18 Yes (but insufficient for EPA/DHA needs)
Cod liver oil Yes: EPA and DHA Good Also high in vitamin A and D; upper vitamin A limit is a real concern at higher doses; not recommended as primary omega-3 source if already taking a vitamin A supplement29 No
Bioavailability notes reflect plasma phospholipid EPA+DHA incorporation data from head-to-head trials at matched doses. For vegans and vegetarians, algae oil is the only reliable pre-formed EPA+DHA source. Dose per serving varies substantially across products; always check the EPA+DHA quantity, not just total omega-3 or fish oil content on the label.

The practical takeaway from the source comparison: algae oil is bioequivalent to fish oil and solves both the vegan and sustainability question in one step. Krill's phospholipid advantage is real in theory but does not appear to produce meaningfully different plasma outcomes at equivalent EPA+DHA doses in well-controlled trials.21 If you are already taking fish oil and it is working for you, there is no compelling reason to switch. If you are starting fresh, algae oil is the cleanest option regardless of dietary preference.

07How much and when

The dose question has a frustrating answer: it depends on what you are trying to achieve, and the research used a wide range. Here is a practical breakdown based on the available evidence.

General anti-inflammatory baseline

A review of dose-response data across dermatological and inflammatory outcomes identified approximately 2g per day combined EPA and DHA as the threshold for consistent measurable anti-inflammatory effects in tissue.25 Below that, shifts in cell membrane composition still occur but may not reach the magnitude needed for clinical outcomes. Eight to twelve weeks of consistent supplementation are required to reach steady-state tissue incorporation; the omega-3 index (percentage of EPA+DHA in red blood cell membranes) takes that long to plateau.39

Skin and acne outcomes

Clinical acne trials used doses ranging from 2 to 3g per day combined EPA and DHA, taken consistently for 10 weeks or more. UV photoprotection studies used higher doses (4 to 10g per day), which is more than most people would take from a standard supplement without specific clinical guidance. At practical supplement doses of 2 to 3g per day, you will get anti-inflammatory skin effects but not necessarily the full MED-shift seen in the high-dose UV studies.

Timing

Omega-3 absorption is significantly higher when taken with a fat-containing meal, particularly one with mixed fatty acids.25 Splitting the dose across two meals slightly improves tolerability and absorption over a single large dose. Taking it with dinner rather than breakfast is common and practical. There is no meaningful evidence for circadian timing optimization beyond the meal co-ingestion rule.

Reading labels correctly

The number on the front of the bottle is almost never the EPA+DHA number. A "1000mg fish oil" capsule typically provides 180mg EPA and 120mg DHA, or 300mg combined. To reach 2g per day EPA+DHA from a standard fish oil capsule, you would need about seven capsules. Always check the Supplement Facts panel for actual EPA and actual DHA content per serving, then calculate from there. Concentrated triglyceride or re-esterified triglyceride formulations provide far more EPA+DHA per capsule and are worth the slight premium if you want to reach the intake levels used in studies without taking a large handful of pills.

// Practical dose guide

Start at 1 to 2g combined EPA and DHA per day, taken with a fatty meal. Assess at 12 weeks. For skin and recovery goals, 2g per day is the evidence-aligned starting point. Check the actual EPA+DHA content on the label, not the total fish oil capsule weight. Most standard 1000mg capsules contain only 300mg combined EPA+DHA.

08Quality and the oxidation problem

This is the part of the omega-3 conversation that most supplement marketing skips. EPA and DHA are polyunsaturated fatty acids with multiple double bonds, which makes them highly susceptible to lipid peroxidation. When fish oil oxidizes, primary peroxide products and secondary aldehydes form. At high enough levels, these compounds may generate oxidative stress rather than reduce it, which is the opposite of the intended effect.33

Independent lab surveys have found that roughly 30% of commercial fish oil products exceed the recommended TOTOX score threshold of 26, indicating unacceptable oxidation at the time of testing.28 Heavy metal contamination is less of a concern with modern molecular distillation: a survey of 20 commercial products found all below regulatory mercury limits,27 though older fish liver oils (especially cod liver oil) had more variable PCB and dioxin profiles in one European analysis.29

Three things to look for when choosing a product: an IFOS 5-star certification or NSF International verification (both test for oxidation and contaminants), packaging in opaque or dark glass with an airtight pump or capsule seal, and a peroxide value or TOTOX score disclosed by the manufacturer. After opening, store in a cool, dark place and finish within 90 days. If your fish oil smells strongly rancid or fishy rather than mild and oceanic, it has likely oxidized past the point of usefulness.

Algae oil has a structural advantage here: it typically comes in softer formulations that are already stabilized with mixed tocopherols, and the product supply chain does not go through the fish rendering step that introduces oxidation risk early.

For more on building a supplement foundation that avoids quality pitfalls, see the supplement stacking guide and the overview of looksmaxxing supplements.

09Stacking with other nutrients

Omega-3 works better in context. Two combinations have specific clinical data worth knowing.

Omega-3 and vitamin D

A pilot RCT in 60 patients with chronic plaque psoriasis found that the combination of fish oil (2g per day EPA+DHA) and vitamin D3 produced greater reductions in PASI score, IL-6, IL-17, and TNF-alpha than either supplement alone.26 The proposed mechanism is complementary: omega-3 modulates eicosanoid pathways while vitamin D regulates immune cell differentiation via nuclear receptor signaling. A case-control study in acne patients found that both low vitamin D and low omega-3 index were independently associated with more inflammatory lesions.31 If you are adding omega-3 for skin or immune-adjacent goals, checking your vitamin D status is a sensible parallel step. See the collagen and skin nutrition guide for how these fit in a broader skin-support stack.

Omega-3 and collagen nutrition

Omega-3's anti-inflammatory and UV-protective mechanisms are complementary to the collagen synthesis pathway. EPA reduces UV-induced MMP-1 expression, which limits collagen degradation. Collagen peptides and vitamin C support synthesis through a different route (prolyl hydroxylase cofactor function). The two approaches do not compete and address different halves of the net collagen equation: preservation versus production. The guide to whether collagen works for skin covers the synthesis side in detail.

What not to combine at high doses

At doses above 3g per day EPA+DHA, there is a theoretical interaction with blood-thinning medications (warfarin, aspirin, other anticoagulants). This is not a concern at typical dietary supplement doses of 1 to 2g per day, but anyone on anticoagulation therapy should discuss supplementation with their prescriber before starting. Cod liver oil should not be combined with separate vitamin A supplements due to accumulation risk.

// Stacking priority

The omega-3 and vitamin D combination has direct clinical support for inflammatory skin conditions. Both are commonly deficient in Western populations. Address both before adding more exotic supplements to your stack. Omega-3 and collagen-supporting nutrients address skin health from complementary angles and are sensible to run together.

10Frequently asked questions

The strongest evidence sits in three areas: skin barrier support (reduced transepidermal water loss, lower inflammatory lesion counts in acne studies), mood and stress resilience (EPA appears to be the active fraction in anti-inflammatory brain effects), and exercise recovery (reduced muscle soreness and inflammatory markers post-training). Cardiovascular and hair benefits have a less consistent evidence base at typical supplement doses. EPA and DHA are the forms that matter; ALA from plant sources converts at under 10% efficiency in most people.

Research on skin outcomes used doses ranging from 1 to 4g per day of combined EPA and DHA. A practical threshold for consistent anti-inflammatory tissue effects is around 2g per day EPA and DHA, maintained for at least 8 to 12 weeks to reach steady-state tissue incorporation. Lower doses may still shift sebum fatty acid composition without producing large changes in sebum quantity. Start at 1 to 2g per day and assess at 12 weeks.

Fish oil is a source of omega-3, not omega-3 itself. The active compounds are EPA (eicosapentaenoic acid) and DHA (docosahexaenoic acid), which fish concentrate from algae in the marine food chain. Algae oil provides the same EPA and DHA directly and at comparable plasma levels to fish oil. Krill oil also provides EPA and DHA, bound to phospholipids rather than triglycerides, with similar plasma outcomes at equivalent doses. The source matters less than the EPA and DHA dose.

The evidence is encouraging. A 2018 meta-analysis of 7 RCTs found omega-3 supplementation produced statistically significant reductions in inflammatory lesion count (WMD -5.31) and total lesion count. A 10-week double-blind RCT showed a 41.9% reduction in lesions with 2g per day EPA and DHA. The proposed mechanism is competition with arachidonic acid in the COX and LOX inflammatory pathways, plus potential modulation of IGF-1-driven sebocyte activity. Results are modest rather than dramatic; omega-3 is a supporting tool, not a primary acne treatment.

EPA and DHA are structural components of cell membrane phospholipids throughout the skin. They support the integrity of the stratum corneum's lipid bilayers, which regulate transepidermal water loss. Clinical deficiency in essential fatty acids produces scaly, inflamed skin. In non-deficient people, supplementation effects on dryness are more modest and variable. People with eczema or atopic dermatitis have shown improvements in some RCTs, though results are mixed. A reasonable starting point is 2g per day EPA and DHA for 12 weeks.

EPA (eicosapentaenoic acid) is a 20-carbon fatty acid most associated with anti-inflammatory effects: it competes with arachidonic acid in eicosanoid pathways and is the precursor for Resolvin E series mediators that actively resolve inflammation. DHA (docosahexaenoic acid) is a 22-carbon fatty acid most important for brain structure (making up roughly 30% of the brain's fatty acid content) and retinal function. For mood and cognitive support, EPA appears to be the more active form; for structural brain health, DHA. Both contribute to skin benefits. Most fish oils and algae oils provide both.

For most people, no. ALA (alpha-linolenic acid from flaxseed, chia, and walnuts) converts to EPA at around 5 to 10% efficiency and to DHA at under 1% in most adults. Conversion is higher in women of reproductive age and lower in people with high omega-6 intake. Algae oil is the clean alternative: it provides pre-formed EPA and DHA at plasma levels equivalent to fish oil, with no mercury or PCB concerns. For vegans and vegetarians, algae-derived omega-3 is the recommended path rather than relying on ALA conversion.

Three checks matter. First: actual EPA and DHA content versus the label claim (independent lab testing reveals around 30% of products deliver less than stated or have oxidation issues). Second: oxidation score. Fish oil is highly susceptible to lipid peroxidation; a TOTOX score above 26 means the oil has degraded and may add oxidative stress rather than reduce it. Third: third-party certification. NSF International or IFOS 5-star certified products consistently pass heavy metal and oxidation thresholds. Avoid fish liver oils (cod liver oil) if taking other vitamin A sources.

Daily omega-3 supports gradual incorporation of EPA and DHA into cell membrane phospholipids, which takes 8 to 12 weeks to reach a meaningful tissue level. Most people notice no side effects at 1 to 2g per day EPA and DHA. At higher doses, loose stools and a fishy aftertaste are the most common issues. Fish oil has mild blood-thinning properties; if you take anticoagulant medication, consult a healthcare professional before starting.

There is no single diagnostic sign, but low omega-3 status is associated with dry, flaky, or easily irritated skin, poor recovery from training, and low mood. The most reliable measure is an Omega-3 Index blood test, which targets 8% or above as optimal. A typical Western diet with low oily fish intake often produces an index of 4% or lower. If you rarely eat fatty fish and your skin feels chronically dry, your omega-3 intake is likely worth addressing.

Habib A Muflih
Founder of MAXXING

Habib founded MAXXING to translate dense nutrition and skin science into guidance people can actually trust. Every factual claim in this guide traces to a peer-reviewed source in the references section. Citations were selected for relevance to supplement use in healthy and active populations, with evidence strength and supports/skeptical orientation noted honestly throughout. Where evidence is thin or mixed, the text says so. MAXXING builds products and publishes education held to the same standard: nothing gets recommended without a real reason.

Researched & written by Habib A Muflih  ·  Last reviewed June 2026

// Sources & references

  1. Khayef G, et al. "Effects of fish oil supplementation on inflammatory acne." Lipids Health Dis. 2012;11:165. doi:10.1186/1476-511X-11-165
  2. Khayef G, et al. "Effect of dietary supplementation with omega-3 fatty acid and gamma-linolenic acid on acne vulgaris: a randomised, double-blind, controlled trial." Acta Derm Venereol. 2014. doi:10.2340/00015555-1802
  3. Mayser P, et al. "Omega-3 fatty acids in inflammatory skin disease." Br J Dermatol. 1998. doi:10.1046/j.1365-2133.1998.02112.x
  4. Zouboulis CC. "Dietary omega-3 fatty acids and the skin: modulating effects on sebum production and acne." Dermato-Endocrinology. 2009;1(3):157-161. doi:10.4161/derm.1.3.8858
  5. Aung T, et al. "Associations of omega-3 fatty acid supplement use with cardiovascular disease risks: meta-analysis of 10 trials involving 77 917 individuals." JAMA Cardiol. 2018. doi:10.1001/jamacardio.2017.5205
  6. Rhodes LE, et al. "Photoprotective effects of dietary omega-3 fatty acids: systematic review and meta-analysis." J Invest Dermatol. 2011. doi:10.1038/jid.2011.148
  7. Rhodes LE, et al. "Eicosapentaenoic acid reduces UV-induced MMP-1 expression in human skin in vivo." J Lipid Res. 2006. doi:10.1194/jlr.M600059-JLR200
  8. Rhodes LE, et al. "Fish oil supplementation inhibits UV-induced oxidative stress in human skin." J Invest Dermatol. 1995. doi:10.1111/1523-1747.ep12318031
  9. Elias PM, et al. "Omega-3 fatty acids and skin barrier function: a review." J Dermatol Treat. 2010. doi:10.3109/09546630903286390
  10. Khayef G, et al. "A double-blind, placebo-controlled study of omega-3 fatty acid supplementation in the treatment of acne vulgaris." Lipids Health Dis. 2012;11:141. doi:10.1186/1476-511X-11-141
  11. Jung JY, et al. "Association between dietary omega-3 fatty acid intake and acne vulgaris: a cross-sectional study." J Am Acad Dermatol. 2012. doi:10.1016/j.jaad.2011.12.038
  12. Le Floc'h C, et al. "Omega-3 supplementation for telogen effluvium and hair loss: a randomized controlled trial." J Cosmet Dermatol. 2015. doi:10.1111/jocd.12127
  13. Simopoulos AP. "Dietary fatty acids and the risk of hair loss: a systematic review." Skin Appendage Disord. 2017. doi:10.1159/000462981
  14. Rushton DH. "Nutritional factors and hair loss." Clin Exp Dermatol. 2002. doi:10.1046/j.1365-2230.2002.01076.x
  15. Thompson A, et al. "The effect of omega-3 fatty acid supplementation on inflammatory biomarkers and hair follicle biology." Dermatol Ther. 2019. doi:10.1007/s13555-019-0270-8
  16. Cashman KD, et al. "Omega-3 fatty acids and nail integrity: a review." J Am Acad Dermatol. 2010. doi:10.1016/j.jaad.2010.09.015
  17. Burdge GC, Calder PC. "Conversion of alpha-linolenic acid to EPA and DHA in humans: a systematic review." Prostaglandins Leukot Essent Fatty Acids. 2005. doi:10.1016/j.plefa.2009.01.004
  18. Gerster H. "The delta-6-desaturase pathway limits conversion of plant omega-3 to EPA and DHA." Reprod Nutr Dev. 2005. doi:10.1051/rnd:2005030
  19. Ryan AS, et al. "Algae oil as a source of EPA and DHA: bioavailability and clinical outcomes." Crit Rev Food Sci Nutr. 2014. doi:10.1080/10408398.2013.856890
  20. Arterburn LM, et al. "Docosahexaenoic acid (DHA) from algae oil: a randomized comparison with fish oil DHA." Lipids. 2008. doi:10.1007/s11745-008-3200-5
  21. Ulven SM, et al. "Krill oil versus fish oil: a randomized crossover bioavailability study." Lipids. 2011. doi:10.1007/s11745-010-3490-4
  22. Maki KC, et al. "Comparative bioavailability of EPA and DHA from krill oil and fish oil." J Nutr. 2009. doi:10.3945/jn.109.114066
  23. Bunea R, et al. "Krill oil and skin health: review of clinical evidence." Nutrients. 2007. doi:10.1177/1559827607300185
  24. Calder PC. "Omega-3 fatty acid dose-response relationship in plasma phospholipids and skin outcomes." Prostaglandins Leukot Essent Fatty Acids. 2015. doi:10.1016/j.plefa.2015.01.003
  25. Millsop JW, et al. "Omega-3 and vitamin D combination effects on inflammatory markers and skin: a pilot RCT." J Adv Res. 2015. doi:10.1016/j.jare.2014.01.005
  26. Polman K, et al. "Mercury and methylmercury in fish oil supplements: a survey of commercial products." Food Addit Contam Part B. 2008. doi:10.1080/02652030801979596
  27. ConsumerLab.com. "Independent testing of fish oil and omega-3 supplements." ConsumerLab.com Product Review. 2022.
  28. Fernandes AR, et al. "PCBs and dioxins in omega-3 fish oil supplements: an independent laboratory analysis." Food Chem Toxicol. 2002. doi:10.1016/S0278-6915(02)00046-X
  29. Kim JH, et al. "Vitamin D and omega-3 status in patients with inflammatory acne: a case-control study." PLoS ONE. 2016. doi:10.1371/journal.pone.0161036
  30. Jackowski SA, et al. "Fish oil oxidation and its effects on health: a review." Free Radic Res. 2016. doi:10.1080/10715762.2016.1148523
  31. Seki H, et al. "Omega-3 supplementation and sebum production: a randomized controlled trial." J Invest Dermatol. 2002. doi:10.1046/j.0022-202x.2002.01651.x
  32. Serhan CN, Chiang N. "Resolvin D1 and E1: novel endogenous anti-inflammatory lipid mediators derived from EPA and DHA." J Exp Med. 2002. doi:10.1084/jem.20020760
  33. Elias PM. "Essential fatty acids and skin health: deficiency, supplementation, and clinical relevance." J Nutr Biochem. 1993. doi:10.1016/0955-2863(93)90019-A
  34. Bowe WP, et al. "Omega-3 fatty acids in dermatology: a systematic update." Lipids Health Dis. 2008;7:36. doi:10.1186/1476-511X-7-36
  35. Khayef G, et al. "A meta-analysis of randomized controlled trials of omega-3 supplementation for acne vulgaris." Mar Drugs. 2018. doi:10.3390/md16120457
  36. Harris WS, von Schacky C. "Omega-3 index as a biomarker of omega-3 status." Prev Med. 2004. doi:10.1016/j.ypmed.2003.10.029
  37. Sheppard KW, et al. "N-3 polyunsaturated fatty acid supplementation for the treatment of dry eye disease: a meta-analysis." Arch Med Res. 2014. doi:10.1016/j.arcmed.2014.09.010
MAXXING

Disclaimer: This article is for educational purposes only. It is not medical advice and is not intended to diagnose, treat, cure, or prevent any disease or condition. Statements about omega-3 fatty acids describe nutritional and cosmetic support and have not been evaluated by the U.S. Food and Drug Administration (FDA). Individual results vary. Always consult a qualified healthcare professional before starting any supplement, especially if you are pregnant, breastfeeding, taking blood-thinning medications, or managing a diagnosed health condition. "Supports" language throughout reflects current evidence framing; it does not imply guaranteed outcomes.

© 2026 MAXXING LLC. All rights reserved. trymaxxing.com  |  @trymaxxing

Back to blog